About this Journal

Aims and scope

Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi’s sarcoma, are published as well as preclinical and animal studies.

This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients. It is of interest to all those working with bone and soft tissue tumours, including medical, surgical and paediatric oncologists, radiotherapists, pathologists and research scientists.

    Bibliographic information

    ISSN: 1076-2787 (Print)
    ISSN: 1099-0526 (Online)
    DOI: 10.1155/8503



      Editorial enquiries should be directed to

         Journal metrics
        Acceptance rate47%
        Submission to final decision67 days
        Acceptance to publication55 days
        Impact Factor-

        We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.